The COVID-19 vaccine is effective against current variants, but the new one may prove more difficult, says Inglesby


The director of the Johns Hopkins Bloomberg School of Public Health’s Center for Health Security, Drs. Tom Inglesby said on Sunday that while COVID-19 vaccines prove effective against current variants, this may not continue in the case of more variants. Emerge.

Inglisby expressed concern about recently discovered variants, particularly the South Africa version, which has reportedly demonstrated resistance to certain treatments and possibly the vaccine itself.

“What we’re seeing is in variants that were found in South Africa, at least in mild to moderate disease, with some of the effects of vaccine studies showing little,” Inglesby confirmed to “Fox News Sunday” While Chris Wallace hosts. Given that “we still have enough pillow with vaccines that they will still be very effective at this point.”

Director of the Bloomberg School of Public Health at the Johns Hopkins Center for Health Security, Drs. Tom Inglesby speaks to Johns Hopkins University medical and research staff during a briefing on the development of the novel coronavirus, also known as COVID-19. March 6, 2020, on Capitol Hill in Washington, DC (Photo by Samuel Corum / Getty Image)

Inglesby cautioned, however, that “this is a message saying that this virus is developing and can continue to develop in ways that make it more dangerous – either more communicable or more deadly.” “

Inglesby praised Johnson & Johnson’s vaccine, however, saying it was a “surprising” development that provides a much-needed boost as the country pushes more people to vaccinate in an aggressive campaign.

10 Republic Rolls $ 600B STIMULUS Plan As Cassidy Buys When He ‘Never Exited’

He also suggested that new variants were responsible for testing the Johnson & Johnson vaccine – an element for which Pfizer and the modern vaccine could not be tested earlier – and that the low efficacy of the Johnson & Johnson vaccine may involve.

The vaccine also appears to improve efficacy over time, reaching a potential 85% protection against all strains after 28 days.

The vaccine can help reopen schools. Experts point to “community dissemination” as the most important factor when deciding whether or not to reopen schools, and more vaccines will help bring that trend down.

Click here to get the Fox News app

“Until there is a community spread of the disease around them,” Inglesby said of the school’s reopening. “And so this is really encouraging news, but what we see is that the schools that have the resources can implement those things, and many schools in the country are not able to implement those things.”

Leave a Reply

Your email address will not be published.